DocGo Inc. (NASDAQ:DCGO) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. boosted its holdings in DocGo Inc. (NASDAQ:DCGO) by 5.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 770,210 shares of the company’s stock after acquiring an additional 40,150 shares during the period. Charles Schwab Investment Management Inc. owned 0.75% of DocGo worth $2,557,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Deerfield Management Company L.P. Series C grew its stake in shares of DocGo by 41.0% during the second quarter. Deerfield Management Company L.P. Series C now owns 7,195,956 shares of the company’s stock worth $22,236,000 after purchasing an additional 2,091,569 shares in the last quarter. Harbor Capital Advisors Inc. boosted its stake in DocGo by 144.6% in the third quarter. Harbor Capital Advisors Inc. now owns 968,537 shares of the company’s stock valued at $3,216,000 after acquiring an additional 572,522 shares in the last quarter. Marshall Wace LLP boosted its stake in DocGo by 212.4% in the second quarter. Marshall Wace LLP now owns 505,514 shares of the company’s stock valued at $1,562,000 after acquiring an additional 343,692 shares in the last quarter. Isthmus Partners LLC boosted its stake in DocGo by 32.4% in the second quarter. Isthmus Partners LLC now owns 799,296 shares of the company’s stock valued at $25,000 after acquiring an additional 195,428 shares in the last quarter. Finally, AQR Capital Management LLC boosted its stake in shares of DocGo by 58.5% during the second quarter. AQR Capital Management LLC now owns 344,963 shares of the company’s stock worth $1,066,000 after buying an additional 127,320 shares during the period. 56.44% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $5.00 target price on shares of DocGo in a report on Friday, September 20th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $6.10.

DocGo Stock Performance

DocGo stock opened at $4.29 on Monday. The firm’s 50-day moving average is $3.80 and its 200-day moving average is $3.48. DocGo Inc. has a 1 year low of $2.75 and a 1 year high of $5.70. The company has a market cap of $437.80 million, a P/E ratio of 15.32, a PEG ratio of 3.81 and a beta of 0.98.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.